Damigin Neurotone Oral Drop inhibits binding of platelet-activating factor (PAF) to platelets resulting in inhibited platelet aggregation and increased blood fluidity; reduces thrombosis, improvements in cognition, working memory, short-term visual memory in dementia, short-term memory in cerebral insufficiency, social functioning in people with dementia, concentration in people with dementia, attention in people with dementia, tinnitus in people with dementia, activities of daily living (ADL) scores in people under 60 years old, mood and sleep in older individuals.